Concepedia

Katelyn R. Keyloun

KR

22

Publications

1.1K

Citations

16

H-Index

2010

Active since

Affiliations

University of Washington(Current)

Allergan (United States)

AbbVie (United States)

Center for Infectious Disease Research

University of Colorado Denver

Katelyn R. Keyloun is an author at University of Washington specializing in medicine, drug discovery, and natural sciences.

Top concepts

Publications per year

2010–2022

22

Publications

22

Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors

Kayode K. Ojo, E.T. Larson, Katelyn R. Keyloun et al. · Nature Structural & Molecular Biology · 2010 · 184 citations · Full text

, , +6

Discovery of Potent and Selective Inhibitors of CDPK1 from <i>C. parvum</i> and <i>T. gondii</i>

Ryan C. Murphy, Kayode K. Ojo, E.T. Larson et al. · ACS Medicinal Chemistry Letters · 2010 · 138 citations · Full text

, , +22

Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)

Katelyn R. Keyloun, Ryan N. Hansen, Zsolt Hepp et al. · CNS Drugs · 2017 · 90 citations · Full text

A Novel Calcium-Dependent Protein Kinase Inhibitor as a Lead Compound for Treating Cryptosporidiosis

Alejandro Castellanos-González, A. Clinton White, Kayode K. Ojo et al. · The Journal of Infectious Diseases · 2013 · 77 citations · Full text

Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy

Kayode K. Ojo, Molly C. Reid, Latha Kallur Siddaramaiah et al. · PLoS ONE · 2014 · 72 citations · Full text

, , +17

Rows per page

1–5 of 22